Guest-induced porous gating of a fluorescent nonporous adaptive crystal for efficient radioactive iodine sorption. [PDF]
Zhang Q +10 more
europepmc +1 more source
Analysis of the impact of Graves' disease on the efficacy of initial radioactive iodine therapy in patients with differentiated thyroid cancer. [PDF]
Wu P +6 more
europepmc +1 more source
Chronotherapeutic optimization of radioactive iodine therapy in differentiated thyroid cancer: The rationale for evening administration. [PDF]
Meristoudis G, Savvidis C, Ilias I.
europepmc +1 more source
Clinical and metabolic factors associated with response to postoperative radioactive iodine therapy in Chinese obese patients with papillary thyroid carcinoma. [PDF]
Zhou Y +11 more
europepmc +1 more source
Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning. [PDF]
Tachibana S +9 more
europepmc +1 more source
Therapeutic Potential of Sodium Selenite Application for Promoting Radioactive Iodine Avidity in Papillary Thyroid Cancer. [PDF]
Oh JM +4 more
europepmc +1 more source
Consideration of Radioactive Iodine Therapy in a Graves' Disease Patient with Secondary Psychosis: A Case Report. [PDF]
Sultan VU +3 more
europepmc +1 more source
Longitudinal dynamics of symptom networks in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a prospective cohort study. [PDF]
Deng J, Deng Q, Zhang L.
europepmc +1 more source
Oral Hyperpigmentation Secondary to Radioactive Iodine Therapy. [PDF]
Boice RM +3 more
europepmc +1 more source
Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer. [PDF]
Sia Y, Mihai R.
europepmc +1 more source

